Bio-Rad Laboratories Class B
BIO.B
4 hedge funds and large institutions have $4.79M invested in Bio-Rad Laboratories Class B in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
14% more capital invested
Capital invested by funds: $4.21M → $4.79M (+$583K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% less ownership
Funds ownership: 0.58% → 0.58% (-0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$15.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $3.63M | – | – | – |
|
|
2
Dimensional Fund Advisors
Austin,
Texas
| $1.03M | -$15.8K | -103 | -2% |
|
3
UBS Group
Zurich,
Switzerland
| $128K | – | – | – |
|
4
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
BIO.B Hedge Fund Activity: Q3 2016 in Review
4 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2016, worth a combined $4.79M — up 14% from $4.21M a quarter earlier.
Fund positioning in BIO.B was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Dimensional Fund Advisors, cutting an estimated $15.8K.
- 4 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $4.79M of Bio-Rad Laboratories Class B stock for Q3 2016, up 14% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q3 2016 and 0 closed out.
- The largest Bio-Rad Laboratories Class B seller in Q3 2016 was Dimensional Fund Advisors, an estimated $15.8K sold.
Based on aggregated 13F filings for Q3 2016.